Illustration of a balance scale comparing a woman on one side with semaglutide medication and a pill bottle on the other, representing the question of whether semaglutide is a game-changer or a cause for concern in diabetes care.

World Diabetes Day Spotlight: Semaglutide & Diabetes—A Game-Changer or Cause for Concern?

Published November 14 – World Diabetes Day Every year on November 14, healthcare professionals, patients, and advocates around the globe come together to recognize World Diabetes Day—a day dedicated to awareness, education, prevention, and empowerment. This year, one medication continues to dominate headlines, clinic discussions, and social media buzz: Semaglutide. Some call it groundbreaking. Others […]
Read More
Semaglutide for weight loss

Semaglutide for Weight Loss: Benefits, Risks, and Ethical Implications

Semaglutide is a GLP-1 receptor agonist originally approved for managing Type 2 diabetes. Recent clinical trials have shown its efficacy in weight loss, leading to its approval for chronic weight management in individuals with obesity. However, semaglutide use solely for weight loss has sparked debate within the medical community. This controversy encompasses several critical aspects, […]
Read More